EDRH
DNLI icon

Edmond de Rothschild Holding’s Denali Therapeutics DNLI Stock Holding History

Edmond de Rothschild Holding’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.25M Sell
165,080
-60,600
-27% -$1.25M 0.06% 192
2026
Q1 		$4.33M Hold
225,680
– – 0.06% 180
2025
Q4 		$3.73M Buy
225,680
+20,000
+10% +$338K 0.05% 189
2025
Q3 		$2.99M Hold
205,680
– – 0.05% 207
2025
Q2 		$2.88M Hold
205,680
– – 0.05% 205
2025
Q1 		$2.8M Hold
205,680
– – 0.05% 200
2024
Q4 		$4.19M Hold
205,680
– – 0.07% 180
2024
Q3 		$5.99M Hold
205,680
– – 0.1% 154
2024
Q2 		$4.78M Hold
205,680
– – 0.08% 167
2024
Q1 		$4.22M Buy
205,680
+40,000
+24% +$752K 0.07% 171
2023
Q4 		$3.56M Buy
165,680
+65,800
+66% +$1.3M 0.06% 187
2023
Q3 		$2.06M Hold
99,880
– – 0.04% 236
2023
Q2 		$2.95M Hold
99,880
– – 0.06% 219
2023
Q1 		$2.3M Hold
99,880
– – 0.05% 235
2022
Q4 		$2.78M Hold
99,880
– – 0.06% 208
2022
Q3 		$3.06M Hold
99,880
– – 0.08% 198
2022
Q2 		$2.94M Hold
99,880
– – 0.07% 215
2022
Q1 		$3.21M Hold
99,880
– – 0.07% 201
2021
Q4 		$4.46M Sell
99,880
-120
-0.1% -$5.68K 0.1% 183
2021
Q3 		$5.04M Buy
100,000
+22,800
+30% +$1.29M 0.12% 163
2021
Q2 		$6.06M Buy
77,200
+20,200
+35% +$1.25M 0.14% 150
2021
Q1 		$3.25M Buy
57,000
+42,000
+280% +$2.81M 0.09% 196
2020
Q4 		$1.26M Buy
+15,000
New +$907K 0.04% 271

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Edmond de Rothschild Holding's DNLI Position: Q2 2026 in Review

Edmond de Rothschild Holding reduced its Denali Therapeutics (DNLI) stake by 27% in Q2 2026, selling an estimated $1.25M and leaving 165,080 shares worth $4.25M. The position accounts for 0.06% of the portfolio, ranked #192.

Edmond de Rothschild Holding first reported a position in DNLI in Q4 2020 and has held it in 23 quarters since. The position peaked at $6.06M in Q2 2021. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Edmond de Rothschild Holding held 165,080 shares of Denali Therapeutics worth $4.25M as of Q2 2026.
  • Edmond de Rothschild Holding sold 60,600 Denali Therapeutics shares in Q2 2026, an estimated $1.25M.
  • Denali Therapeutics made up 0.06% of Edmond de Rothschild Holding's portfolio in Q2 2026, its #192 holding.
  • Edmond de Rothschild Holding first reported a position in Denali Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • Edmond de Rothschild Holding's Denali Therapeutics position peaked at $6.06M in Q2 2021.
  • 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2026, filed 10 Aug 2026.